» Articles » PMID: 30580963

Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2018 Dec 25
PMID 30580963
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Here, we present Perturb-ATAC, a method that combines multiplexed CRISPR interference or knockout with genome-wide chromatin accessibility profiling in single cells based on the simultaneous detection of CRISPR guide RNAs and open chromatin sites by assay of transposase-accessible chromatin with sequencing (ATAC-seq). We applied Perturb-ATAC to transcription factors (TFs), chromatin-modifying factors, and noncoding RNAs (ncRNAs) in ∼4,300 single cells, encompassing more than 63 genotype-phenotype relationships. Perturb-ATAC in human B lymphocytes uncovered regulators of chromatin accessibility, TF occupancy, and nucleosome positioning and identified a hierarchy of TFs that govern B cell state, variation, and disease-associated cis-regulatory elements. Perturb-ATAC in primary human epidermal cells revealed three sequential modules of cis-elements that specify keratinocyte fate. Combinatorial deletion of all pairs of these TFs uncovered their epistatic relationships and highlighted genomic co-localization as a basis for synergistic interactions. Thus, Perturb-ATAC is a powerful strategy to dissect gene regulatory networks in development and disease.

Citing Articles

Systematic reconstruction of molecular pathway signatures using scalable single-cell perturbation screens.

Jiang L, Dalgarno C, Papalexi E, Mascio I, Wessels H, Yun H Nat Cell Biol. 2025; 27(3):505-517.

PMID: 40011560 DOI: 10.1038/s41556-025-01622-z.


Decoding heterogeneous single-cell perturbation responses.

Song B, Liu D, Dai W, McMyn N, Wang Q, Yang D Nat Cell Biol. 2025; 27(3):493-504.

PMID: 40011559 PMC: 11906366. DOI: 10.1038/s41556-025-01626-9.


Functional analysis of cancer-associated germline risk variants.

Kellman L, Neela P, Srinivasan S, Siprashvili Z, Shanderson R, Hong A Nat Genet. 2025; 57(3):718-728.

PMID: 39962238 DOI: 10.1038/s41588-024-02070-5.


Massively parallel in vivo Perturb-seq screening.

Zheng X, Thompson P, White C, Jin X Nat Protoc. 2025; .

PMID: 39939709 DOI: 10.1038/s41596-024-01119-3.


Phospho-seq: integrated, multi-modal profiling of intracellular protein dynamics in single cells.

Blair J, Hartman A, Zenk F, Wahle P, Brancati G, Dalgarno C Nat Commun. 2025; 16(1):1346.

PMID: 39905064 PMC: 11794950. DOI: 10.1038/s41467-025-56590-7.


References
1.
Zhao B, Barrera L, Ersing I, Willox B, Schmidt S, Greenfeld H . The NF-κB genomic landscape in lymphoblastoid B cells. Cell Rep. 2014; 8(5):1595-606. PMC: 4163118. DOI: 10.1016/j.celrep.2014.07.037. View

2.
Mumbach M, Satpathy A, Boyle E, Dai C, Gowen B, Cho S . Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. Nat Genet. 2017; 49(11):1602-1612. PMC: 5805393. DOI: 10.1038/ng.3963. View

3.
McKercher S, Torbett B, Anderson K, Henkel G, Vestal D, Baribault H . Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996; 15(20):5647-58. PMC: 452309. View

4.
Heath J, Ribas A, Mischel P . Single-cell analysis tools for drug discovery and development. Nat Rev Drug Discov. 2015; 15(3):204-16. PMC: 4883669. DOI: 10.1038/nrd.2015.16. View

5.
Najm F, Strand C, Donovan K, Hegde M, Sanson K, Vaimberg E . Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens. Nat Biotechnol. 2017; 36(2):179-189. PMC: 5800952. DOI: 10.1038/nbt.4048. View